|
Participate in a symposia series featuring Mary Warren, Ph.D., Chief Scientific Officer, Genpathway
|
|
Dr. Warren discusses the Affymetrix/Genpathway partnership, which offers new ChIP-on-chip and methylated DNA assays combining Genpathway's high-quality ChIP/DNA immunoprecipitation (IP) assays with Affymetrix' whole-genome tiling arrays. Dr. Warren discusses how this combination of technologies provides scientists with an immediate, total solution for analyzing gene transcription, gene regulation by transcription factors and epigenetic changes.
→ View the presentation
|
|